Recently, we observed that impairments exist in skeletal muscle free fatty acid (FFA) utilization during exercise in obese subjects with Type II diabetes. The main objective of the present study was to investigate whether plasma FFA oxidation is impaired during exercise in non-obese Type II diabetic patients. Stable isotope tracers of palmitate and glucose were infused for 2h at rest and 1h of bicycle exercise at 40% peak oxygen consumption (VO2max) in volunteers with Type II diabetes and a healthy control group. At rest, plasma FFA oxidation was not significantly different between subjects with Type II diabetes and control subjects (2.13±0.51 versus 1.93±0.54μmolμkg-1μmin-1 respectively). During exercise, Type II diabetic patients and control subjects had similar rates of total fat [Type II diabetes, 9.62±1.84μmolμkg-1μmin-1; control, 12.08±4.59μmolμkg-1μmin-1; not significant (NS)] and glucose oxidation (Type II diabetes, 44.24±10.36μmolμkg-1μmin-1; control, 57.37±14.54μmolμkg-1μmin-1; NS). No aberrations were present in plasma FFA uptake [rate of disappearance (Rd); Type II diabetes, 11.78±4.82; control, 10.84±3.39; NS] and oxidation rates (Type II diabetes 8.10±1.44; control 8.00±3.12, NS) in Type II diabetic patients; triacylglycerol-derived fatty acid oxidation was 2.6-fold lower in Type II diabetic patients than in control subjects, but this difference was not statistically significant. Muscle glycogen oxidation was lower in diabetes patients than in control subjects (Type II diabetes, 25.16±13.82μmolμkg-1μmin-1; control, 42.04±10.58μmolμkg-1μmin-1; P<0.05) and plasma glucose contributed more to energy expenditure in Type II diabetes (26±3% in diabetic versus 15±2% in control, P<0.05). We conclude that plasma FFA oxidation is not impaired during exercise in non-obese Type II diabetic patients. The data confirm that Type II diabetes is a heterogeneous disease, and that the adaptation at the substrate level differs between obese and non-obese patients and may contribute to differences in the final appearance of the various phenotypes.
Skip Nav Destination
Article navigation
Research Article|
October 30 2002
Substrate utilization in non-obese Type II diabetic patients at rest and during exercise
L.B. BORGHOUTS;
L.B. BORGHOUTS
*Department of Movement Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands
Search for other works by this author on:
A.J.M. WAGENMAKERS;
A.J.M. WAGENMAKERS
†Human Biology, Maastricht University, 6200 MD Maastricht, The Netherlands
Search for other works by this author on:
P.L.L. GOYENS;
P.L.L. GOYENS
†Human Biology, Maastricht University, 6200 MD Maastricht, The Netherlands
Search for other works by this author on:
H.A. KEIZER
*Department of Movement Sciences, Maastricht University, 6200 MD Maastricht, The Netherlands
Correspondence: Dr H.A. Keizer (e-mail [email protected]).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 18 2002
Accepted:
September 04 2002
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 2002
2002
Clin Sci (Lond) (2002) 103 (6): 559–566.
Article history
Received:
June 18 2002
Accepted:
September 04 2002
Citation
L.B. BORGHOUTS, A.J.M. WAGENMAKERS, P.L.L. GOYENS, H.A. KEIZER; Substrate utilization in non-obese Type II diabetic patients at rest and during exercise. Clin Sci (Lond) 1 December 2002; 103 (6): 559–566. doi: https://doi.org/10.1042/cs1030559
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |